Back
Lonza Group Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
24
LZAGY
Lonza Group
Last Price:
58.38
Seasonality Move:
8.66%
Sell
27
NLSP
NLS Pharmaceutics
Last Price:
3.48
Seasonality Move:
43.45%
Sell
24
Lonza Group (LZAGY)
is a Sell
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGY] share price is $58.38. The Score for LZAGY is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- LZAGY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.43. The Score for NLSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGY Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $58.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LZAGY is experiencing slight selling pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
LZAGY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.16 | Sell |
Relative Strength Index (14 RSI): | 36.42 | Sell |
Chaikin Money Flow: | -139609 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (59.56 - 63.7) | Sell |
Bollinger Bands (100): | (59.54 - 65.1) | Sell |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 39.11 | Sell |
Chaikin Money Flow: | -22778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.4 - 4.36) | Sell |
Bollinger Bands (100): | (4.21 - 7.55) | Sell |
LZAGY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.24 | Sell |
20-day SMA: | 61.27 | Sell |
50-day SMA: | 62.23 | Sell |
200-day SMA: | 58.87 | Sell |
8-day EMA: | 59.26 | Sell |
20-day EMA: | 60.66 | Sell |
50-day EMA: | 61.69 | Sell |
200-day EMA: | 58.82 | Sell |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.31 | Buy |
20-day SMA: | 3.72 | Sell |
50-day SMA: | 4.51 | Sell |
200-day SMA: | 7.27 | Sell |
8-day EMA: | 3.42 | Buy |
20-day EMA: | 3.73 | Sell |
50-day EMA: | 4.47 | Sell |
200-day EMA: | 9.25 | Sell |
Lonza Group Earnings Growth & LZAGY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lonza Group Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |